Thus, to confirm the specific roles of IL-33 and Hcy in DN is in a great need, which may help scientists and physician to develop novel therapies for improved therapeutic efficacy of current methods for the management of DN. The gene discussed is IL33; the disease is liver dysplastic nodule.